DOC vs HR Stock Comparison

Healthpeak Properties and Healthcare Realty Trust Prices as of Oct 23, 2026 Peers: Industry group

Head to Head

7 decided of 12

Healthpeak Properties leads on 6 of the 12 questions below (Healthpeak Properties 6, Healthcare Realty Trust 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionDOCHRLeader
Larger companyMarket capitalisation $13.34B $6.14B DOC
Cheaper on earningsLower P/E, profitable companies only 55.0x -70.7x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 40.1x — –
Faster revenue growthRevenue growth, trailing twelve months +5.5% -6.3% DOC
More profitableNet margin, trailing twelve months 8.2% -7.6% DOC
Better return on capitalReturn on invested capital 1.4% — –
Less leveragedLower net debt / EBITDA 3.8x — –
Higher dividend yieldTrailing dividend yield 0.00% 0.05% –
Better 1-year returnPrice return, last 12 months +3.8% -4.1% DOC
Better 5-year returnAnnualised price return, 5 years -11.1%/yr -11.4%/yr DOC
Less volatileAnnualised volatility, 1 year 29.1% 19.9% HR
Higher overall scoreMean of the five percentile scores vs peers 59/100 43/100 DOC

Percentile Scorecard

DOCHR

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisDOCHR
Valuation 54 #68 of 145 40 #88 of 145
Growth 37 #91 of 144 54 #67 of 144
Profitability 53 #67 of 140 34 #93 of 140
Financial Health 66 #51 of 146 49 #75 of 146
Shareholder Returns 87 #18 of 132 41 #79 of 132
Overall 59 43
  • DOC ranked among 149 companies in Property REITs
  • HR ranked among 149 companies in Property REITs

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodDOCHRSPY
1 month -6.1%-0.3% -1.0%
3 months -13.6%-16.3% +2.9%
6 months +17.1%-4.2% +6.4%
Year to date +19.7%+5.7% +11.4%
1 year +3.8%-4.1% +13.1%
3 years +13.4%+23.0% +79.4%
3 years, per year +4.3%+7.1% +21.5%
5 years -44.6%-45.4% +67.7%
5 years, per year -11.1%-11.4% +10.9%
10 years -46.3%-45.1% +255.2%
10 years, per year -6.0%-5.8% +13.5%

Risk

MeasureDOCHRSPY
Volatility, 1Y 29.1%19.9% 12.7%
Downside volatility, 1Y 25.3%19.9% 12.7%
Beta vs S&P 500, 1Y 0.390.10 1.00
Return / volatility, 1Y 0.13-0.20 1.03
Max drawdown, 5Y -57.6%-61.6% -25.4%
From 52-week high -15.7%-18.1% -2.5%
52-week high $22.83$21.89 $779.14
52-week low $15.78$16.34 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleDOCHR
P/E now vs peer median 54.7xmedian 27.0x -70.6xmedian 27.0x
P/S now vs peer median 4.5xmedian 4.1x 5.4xmedian 4.1x
EV/EBITDA now vs peer median 13.5xmedian 14.5x —median 14.5x
P/FCF now vs peer median -20.4xmedian 23.7x 49.7xmedian 23.7x
P/B now vs peer median 1.4xmedian 1.3x 1.4xmedian 1.3x
PEG now vs peer median -1.91median 2.07 -3.83median 2.07

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsDOCHR
Revenue $2.95B $1.14B
Net income $289.42M -$87.96M
Free cash flow -$650.07M $123.68M
EPS (diluted) $0.35 $-0.25
Cash & equivalents $1.63B $18.99M
Total debt $27.10B $4.17B
Shares (diluted) 689.89M 342.30M
Enterprise value $9.99B $6.03B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricDOCHR
P/E 54.7x -70.6x
P/FCF -20.4x 49.7x
P/Operating cash flow 10.8x 13.9x
P/S 4.5x 5.4x
P/B 1.4x 1.4x
P/Tangible book 1.5x 1.4x
EV/EBITDA 13.5x –
EV/EBIT 83.0x –
EV/Revenue 6.2x 9.0x
EV/FCF -28.3x 83.2x
EV/Operating cash flow 15.0x 23.3x
PEG (3Y EPS CAGR) -1.91 -3.83

Growth

14 metrics
MetricDOCHR
Revenue growth (1Y) 5.5% -6.3%
Revenue CAGR (3Y) 11.7% -4.5%
Gross profit growth (1Y) – –
Gross profit CAGR (3Y) – –
Operating income growth (1Y) – –
Operating income CAGR (3Y) – –
Net income growth (1Y) 50.4% 78.5%
Net income CAGR (3Y) -19.7% 21.1%
EPS growth (1Y) 49.2% 77.9%
EPS CAGR (3Y) -28.6% 18.4%
Operating cash flow growth (1Y) -1.1% -5.8%
Operating cash flow CAGR (3Y) 10.1% 2.2%
Free cash flow growth (1Y) -263.9% -8.9%
Free cash flow CAGR (3Y) -85.6% 314.6%

Profitability

14 metrics
MetricDOCHR
Gross margin – –
EBITDA margin 46.3% –
Operating margin – –
Pretax margin 15.1% –
Net margin 8.2% -7.6%
FCF margin -22.0% 10.8%
Operating cash flow margin 41.7% 38.5%
Return on equity 3.0% -2.0%
Return on assets 1.3% -1.0%
Return on invested capital 1.4% –
Return on capital employed – –
Asset turnover 0.1x 0.1x
Cash conversion (OCF / net income) 4.3x -5.0x
Stock comp / revenue 0.6% 1.8%

Financial Health

11 metrics
MetricDOCHR
Debt / assets 31.3% 46.3%
Debt / equity 0.7x 1.0x
Net debt / EBITDA 3.8x –
Debt / FCF -10.4x 33.7x
Liabilities / assets 56.3% 52.6%
Equity / assets 43.7% 47.4%
Interest coverage 1.4x –
Current ratio – –
Quick ratio – –
Cash ratio – –
Altman Z-score – –

Shareholder Returns

7 metrics
MetricDOCHR
Dividend yield 6.3% 5.4%
Net buyback yield 0.8% 2.9%
Shareholder yield 7.0% 8.3%
Payout ratio (earnings) – -381.2%
Payout ratio (FCF) – 271.1%
Dividend growth (1Y) – -23.8%
Dividend CAGR (3Y) – -7.7%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusDOCHR
Forward P/E 40.1xFY2026 –
EPS, next fiscal year $0.48FY2026 $-0.10FY2026
EPS growth, next FY +380.0%FY2026 –
EPS growth, the year after -52.1% –
Revenue, next fiscal year $2.86BFY2026 $1.17BFY2026
Revenue growth, next FY +3.7%FY2026 -0.7%FY2026
Revenue growth, the year after +16.5% -8.1%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersDOCHR
Held by institutions 95.7% 100.0%
Institutions holding 759 458
Change in shares held, QoQ -2.9% +0.8%
Institutions buying 341 225
Institutions selling 312 145
Buyers to sellers 1.09 1.55

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

DOCHR
DOC 1.00 0.58
HR 0.58 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, DOC and HR?

Healthpeak Properties (DOC) is the largest by market capitalisation: Healthpeak Properties (DOC) $13.34B, Healthcare Realty Trust (HR) $6.14B.

Which company is growing faster?

Healthpeak Properties (DOC) grew revenue fastest over the trailing twelve months: Healthpeak Properties (DOC) +5.5%, Healthcare Realty Trust (HR) -6.3%.

Which company is more profitable?

Healthpeak Properties (DOC) has the highest net margin (Healthpeak Properties (DOC) 8.2%, Healthcare Realty Trust (HR) -7.6%).

Which stock has performed better?

Over the past year Healthpeak Properties (DOC) returned the most: Healthpeak Properties (DOC) +3.8%, Healthcare Realty Trust (HR) -4.1%. Over five years, Healthpeak Properties (DOC) compounded fastest (Healthpeak Properties (DOC) -11.1%/yr, Healthcare Realty Trust (HR) -11.4%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Healthpeak Properties (DOC) 0.00%, Healthcare Realty Trust (HR) 0.05%. Healthpeak Properties (DOC) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Healthcare Realty Trust (HR) has been the steadiest (Healthpeak Properties (DOC) 29.1%, Healthcare Realty Trust (HR) 19.9%). Volatility measures how widely the price swings, not the risk of the business.

Do DOC and HR move together?

Their daily returns over the past year have a correlation of 0.58, a moderate positive relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, DOC and HR?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Healthpeak Properties (DOC) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.